Image: Shutterstock

Madri­gal to grap­ple with lack of aware­ness about NASH ahead of po­ten­tial FDA ap­proval

Madri­gal Phar­ma­ceu­ti­cals may be first in line to bring a NASH drug to mar­ket, but the com­pa­ny is al­so tasked with teach­ing Amer­i­cans and their …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.